The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Oxytocin Infusion Reduces Repetitive Behaviors in Adults with Autistic and Asperger's Disorders
Abstract
Autism is a neurodevelopmental disorder characterized by dysfunction in three core behavioral domains: repetitive behaviors, social deficits, and language abnormalities. There is evidence that abnormalities exist in peptide systems, particularly the oxytocin system, in autism spectrum patients. Furthermore, oxytocin and the closely related peptide vasopressin are known to play a role in social and repetitive behaviors. This study examined the impact of oxytocin on repetitive behaviors in 15 adults with autism or Asperger's disorder via randomized double-blind oxytocin and placebo challenges. The primary outcome measure was an instrument rating six repetitive behaviors: need to know, repeating, ordering, need to tell/ask, self-injury, and touching. Patients with autism spectrum disorders showed a significant reduction in repetitive behaviors following oxytocin infusion in comparison to placebo infusion. Repetitive behavior in autism spectrum disorders may be related to abnormalities in the oxytocin system, and may be partially ameliorated by synthetic oxytocin infusion.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Improvements in repetitive behaviors in adults with autism following oxytocin infusion have been demonstrated [169] as well as positive effects on social behaviors and cognition [170].”
From Consensus Paper: Pathological Role of the Cerebellum in Autism (2012) · cites this paper as [169]
In the citing paper
“The neuromodulator oxytocin (OT) has been shown to improve social deficits in both ASD and other disorders accompanied by social deficits (Guastella et al., 2010, 2010; Hollander et al., 2002, 2007; Yatawara et al., 2015; Young and Barrett, 2015).”
From Oxytocin enhances gaze-following responses to videos of natural social behavior in adult male rhesus monkeys (2016) · cites this paper as Hollander et al., 2002
In the citing paper
“reduce repetitive behaviors (Hollander et al., 2003)”
From Effects of intranasal oxytocin on social anxiety in males with fragile X syndrome (2012) · cites this paper as Hollander et al., 2003
In the citing paper
“This study demonstrated that administration of OT led to a decrease in a core ASD symptom, RRB.”
From Oxytocin and vasopressin systems in genetic syndromes and neurodevelopmental disorders (2014) · cites this paper as Hollander et al., 2003
In the citing paper
“Overall, these observed effects on repetitive behaviors are in line with previous trials with adult men with ASD showing beneficial effects of OT on repetitive behaviors after 4 h of intravenous OT administration [4] and after 6 weeks of daily administrations [8, 10].”
From Behavioral effects of multiple-dose oxytocin treatment in autism: a randomized, placebo-controlled trial with long-term follow-up (2020) · cites this paper as [4]
In the citing paper
“In this view, it appears that beneficial effects of OT treatment on repetitive behaviors were mostly demonstrated in studies that adopted assessments based on self-reports (current study, [4, 8]), whereas no beneficial effects were evident in studies adopting informant-based reports of repetitive behavior [9–14].”
From Behavioral effects of multiple-dose oxytocin treatment in autism: a randomized, placebo-controlled trial with long-term follow-up (2020) · cites this paper as [4]
In the citing paper
“There is both animal (Popik et al., 1992) and human (Hollander et al., 2007(Hollander et al., , 2003) ) research to suggest systemic OT can influence social behavior and cognition”
From Low dose intranasal oxytocin delivered with Breath Powered device dampens amygdala response to emotional stimuli: A peripheral effect-controlled within-subjects randomized dose-response fMRI trial (2016) · cites this paper as Hollander et al., 2003
In the citing paper
“oxytocin , relative to placebo, reduces repetitive stereotypic behaviors [172]”
From Social “wanting” dysfunction in autism: neurobiological underpinnings and treatment implications (2012) · cites this paper as [172]
Citations
Cites
Lord, C., Rutter, M., & Le Couteur, A. (1994) · Journal of Autism and Developmental Disorders · doi:10.1007/bf02172145 · Cited by 9,065
The neurobiology of attachment
Insel, T. R., & Young, L. J. (2001) · Nature Reviews Neuroscience · doi:10.1038/35053579 · Cited by 1,173
Social amnesia in mice lacking the oxytocin gene
Ferguson, J. N., Young, L. J., Hearn, E. F., Matzuk, M. M., Insel, T. R., & Winslow, J. T. (2000) · Nature Genetics · doi:10.1038/77040 · Cited by 1,130
A role for central vasopressin in pair bonding in monogamous prairie voles
Winslow, J. T., Hastings, N., Carter, C. S., Harbaugh, C. R., & Insel, T. R. (1993) · Nature · doi:10.1038/365545a0 · Cited by 948 · cited 1×
“For males, vasopressin has been shown to evoke partner preference and aggression after mating (Winslow et al, 1993).”
BackgroundOxytocin is required for nursing but is not essential for parturition or reproductive behavior.
Nishimori, K., Young, L. J., Guo, Q., Wang, Z., Insel, T. R., & Matzuk, M. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11699 · Cited by 734
Plasma oxytocin levels in autistic children
Modahl, C., Green, L. A., Fein, D., Morris, M., Waterhouse, L., Feinstein, C., & Levin, H. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00439-3 · Cited by 728
Insel, T. R., & Hulihan, T. J. (1995) · Behavioral Neuroscience · doi:10.1037/0735-7044.109.4.782 · Cited by 528
Oxytocin and autistic disorder: alterations in peptide forms
Green, L., Fein, D., Modahl, C., Feinstein, C., Waterhouse, L., & Morris, M. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01139-8 · Cited by 404
Behavioral effects of intraventricularly administered vasopressin and vasopressin fragments
de Wied, D. (1976) · Life Sciences · doi:10.1016/0024-3205(76)90165-x · Cited by 359
Central Nervous System Effects of the Neurohypophyseal Hormones and Related Peptides
de Wied, D., Diamant, M., & Fodor, M. (1993) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1993.1009 · Cited by 327
Cited by
Sorted by citations
Items 401–500 of 704
What’s in the pipeline? Drugs in development for autism spectrum disorder
Sung, M., Chin, C. H., Lim, C. G., Liew, A., Lim, C. S., Kashala-Abotnes, E., & Weng, S. J. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s39516 · Cited by 20
Glasgow, E. F., Ryu, S.-L., Yamashita, M., Zhang, B.-J., Mutsuga, N., & Gainer, H. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2005.02.030 · Cited by 20
Iwashita, M., & Yoshizawa, M. (2021) · eLife · doi:10.7554/elife.72463 · Cited by 19
Korisky, A., Gordon, I., & Goldstein, A. (2022) · Molecular Autism · doi:10.1186/s13229-022-00513-6 · Cited by 19
Clinical potential of oxytocin in autism spectrum disorder: current issues and future perspectives
Benner, S., & Yamasue, H. (2017) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000341 · Cited by 19
Edwards, K. A., Madden, A. M. K., & Zup, S. L. (2018) · Brain Research · doi:10.1016/j.brainres.2018.07.020 · Cited by 19
Borie, A. M., Theofanopoulou, C., & Andari, E. (2021) · Handbook of clinical neurology · doi:10.1016/b978-0-12-819973-2.00009-5 · Cited by 19
Baribeau, D. A., & Anagnostou, E. A. (2014) · Europe PMC (PubMed Central) · Cited by 19
Schechtman, M. (2007) · Pediatric Annals · doi:10.3928/0090-4481-20070801-12 · Cited by 19
The BTBR T+tf/J (BTBR) Mouse Model of Autism
Chadman, K. K. (2012) · Autism - Open Access · doi:10.4172/2165-7890.s1-009 · Cited by 19
Oxytocin conditions trait-based rule adherence
Gross, J., & Dreu, C. K. W. D. (2016) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsw138 · Cited by 19
Pharmacotherapy for personality disorders
Newton‐Howes, G., & Tyrer, P. J. (2003) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.4.10.1643 · Cited by 19
Tsingotjidou, A. (2022) · Biomolecules · doi:10.3390/biom12111603 · Cited by 18
DNA Methylation in Autism Spectrum Disorders: Biomarker or Pharmacological Target?
Gholamalizadeh, H., Amiri-Shahri, M., Rasouli, F., Ansari, A., Rahimi, V. B., & Askari, V. R. (2024) · Brain Sciences · doi:10.3390/brainsci14080737 · Cited by 18
Jiang, L., Tian, L., Yuan, J., Xu, X., Qu, F., Zhang, R., & Wang, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.789395 · Cited by 18
Sugarman, L. I., Garrison, B., & Williford, K. L. (2013) · American Journal of Clinical Hypnosis · doi:10.1080/00029157.2013.768197 · Cited by 18
Vasudeva, S. B., & Hollander, E. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.16050559 · Cited by 18
Self-citationFriedman, N. D. B., Politte, L. C., Nowinski, L. A., & McDougle, C. J. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch44 · Cited by 17
The Role of the Oxytocin/Arginine Vasopressin System in Animal Models of Autism Spectrum Disorder
Zhang, R., Xu, X., Zhang, H.-F., Han, S., & Han, J. (2017) · Advances in anatomy, embryology and cell biology · doi:10.1007/978-3-319-52498-6_8 · Cited by 17
Asperger Syndrome and Medication Treatment
Tsai, L. Y. (2007) · Focus on Autism and Other Developmental Disabilities · doi:10.1177/10883576070220030101 · Cited by 17
Mechanisms underlying sexual and affiliative behaviors of mice: relation to generalized CNS arousal
Shelley, D. N., Choleris, E., Kavaliers, M., & Pfaff, D. W. (2006) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsl032 · Cited by 17
Anpassungsstörung, akute und posttraumatische Belastungsstörung
Kapfhammer, H. (2003) · Springer eBooks · doi:10.1007/3-540-27386-7_54 · Cited by 17
Pharmacological Treatment for Social Cognition: Current Evidence
Riccardi, C., Montemagni, C., Favero, E. D., Bellino, S., Brasso, C., & Rocca, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147457 · Cited by 16
Intranasal oxytocin in a genetic animal model of autism
Szabó, J., Mlynár, M., Feješ, A., Renczés, E., Borbélyová, V., Ostatníková, D., & Celec, P. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02330-6 · Cited by 16
Oxytocin in neurodevelopmental disorders: Autism spectrum disorder and Prader-Willi syndrome
Josselsohn, A., Zhao, Y., Espinoza, D., & Hollander, E. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108734 · Cited by 16
Self-citationLeng, H., Zhang, X., Wang, Q., Luan, X., Sun, X., Guo, F., Gao, S., Liu, X., & Xu, L. (2019) · Neurogastroenterology & Motility · doi:10.1111/nmo.13655 · Cited by 16
Role of Vitamin D in Autism Spectrum Disorder
Alzghoul, L. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666191122092215 · Cited by 16
Marazziti, D., Diep, P.-T., Carter, C. S., & Carbone, M. G. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220727120646 · Cited by 16
Exposure to synthetic oxytocin during delivery and its effect on psychomotor development
Valenzuela, M. J. G., López‐Montiel, D., & González‐Mesa, E. (2015) · Developmental Psychobiology · doi:10.1002/dev.21321 · Cited by 16
Pharmacotherapy of Suicidal Behavior in Bipolar Disorder
Oquendo, M. A., Chaudhury, S. R., & Mann, J. J. (2005) · Archives of Suicide Research · doi:10.1080/13811110590929424 · Cited by 16
Epidermis as the “Third Brain”?
Denda, M. (2015) · Dermatologica Sinica · doi:10.1016/j.dsi.2015.04.011 · Cited by 16
Welch, M. G., & Ruggiero, D. A. (2005) · International review of neurobiology · doi:10.1016/s0074-7742(05)71012-6 · Cited by 16
Defining repetitive behaviours in frontotemporal dementia
Restrepo-Martínez, M., Ramirez-Bermudez, J., Chacon-Gonzalez, J., Ruiz-Garcia, R., Malik, R., & Finger, E. (2024) · Brain · doi:10.1093/brain/awad431 · Cited by 15
Xu, D., Li, Q., Zhuang, Q., Zhang, Y., Yao, S., Zhao, W., & Kendrick, K. M. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1022101 · Cited by 15
Are there new advances in the pharmacotherapy of autism spectrum disorders?
Hollander, E., & Uzunova, G. (2017) · World Psychiatry · doi:10.1002/wps.20398 · Cited by 15
Self-citationHu, R., Geng, Y., Huang, Y., Liu, Z., Li, F., Dong, H., Ma, W., Song, K., Zhang, M., Zhang, Z., et al. (2023) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.14988 · Cited by 15
Corbett, B. A., Bales, K. L., Swain, D. M., Sanders, K. B., Weinstein, T. A. R., & Muglia, L. J. (2016) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-016-9165-6 · Cited by 14
Behavioral Roles of Oxytocin and Vasopressin
Benjamin, C. (2012) · InTech eBooks · doi:10.5772/50422 · Cited by 14
Psychoendocrinologie sociale de l’ocytocine : revue d’une littérature en pleine expansion
Lane, A., Luminet, O., & Mikolajczak, M. (2013) · L’Année psychologique · doi:10.4074/s0003503313002066 · Cited by 14
Wang, Y., Zhao, S., Wu, Z., Feng, Y., Zhao, C., & Zhang, C. (2015) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12378 · Cited by 13
Brain Mechanisms of Plasticity in Response to Treatments for Core Deficits in Autism
Ventola, P. E., Oosting, D., Anderson, L. C., & Pelphrey, K. A. (2013) · Progress in brain research · doi:10.1016/b978-0-444-63327-9.00007-2 · Cited by 13
Higuchi, Y., Tachigori, S.-I., & Arakawa, H. (2022) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2022.106004 · Cited by 13
Canitano, R. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.11.024 · Cited by 13
Pathologic Evaluation of the Supraoptic and Paraventricular Nuclei in Dementia
Diodati, D., Cyn-Ang, L., Kertesz, A., & Finger, E. C. (2012) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100013251 · Cited by 13
Social impairments among children perinatally exposed to oxytocin or oxytocin receptor antagonist
Friedlander, E., Feldstein, O., Mankuta, D., Yaari, M., Harel‐Gadassi, A., Ebstein, R. P., & Yirmiya, N. (2017) · Early Human Development · doi:10.1016/j.earlhumdev.2017.01.008 · Cited by 13
Bozdoğan, S. T., Kütük, M. Ö., Tufan, A. E., Altıntaş, Z. M., Temel, G. Ö., & Toros, F. (2018) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2018.16.1.415 · Cited by 13
Acupuncture and oxytocinergic system: The promising treatment for autism
Su, T., & Pei, L. (2021) · Translational Neuroscience · doi:10.1515/tnsci-2021-0011 · Cited by 13
Waltenspühl, Y., Jeliazkov, J. R., Kummer, L., & Plückthun, A. (2021) · Scientific Reports · doi:10.1038/s41598-021-87793-9 · Cited by 13
Chan, A. S.-Y., Sze, S. L., & Han, Y. M. Y. (2014) · Research in Autism · doi:10.1016/j.rasd.2014.03.007 · Cited by 13
Psychopharmakologie autistischer Störungen
Poustka, L., Banaschewski, T., & Poustka, F. (2011) · Der Nervenarzt · doi:10.1007/s00115-010-3238-7 · Cited by 13
The Multifaceted Role of Oxytocinergic System and OXTR Gene
Hasan, R. (2024) · Global Medical Genetics · doi:10.1055/s-0044-1779039 · Cited by 12
Review of sensory systems deployed by epidermal keratinocytes
Denda, M., & Elias, P. M. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1598326 · Cited by 12
Lan, C., Chen, Y., Zhang, Y., Kou, J., Huang, L., Xu, T., Yang, X., Xu, D., Yang, W., Kendrick, K. M., et al. (2023) · Neuroendocrinology · doi:10.1159/000531064 · Cited by 12
The Neurobiology and Genetics of Affiliation and Social Bonding in Animal Models
Donaldson, Z. R., & Young, L. J. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3777-6_4 · Cited by 12
Paiva, L., Sabatier, N., Leng, G., & Ludwig, M. (2016) · Journal of Neuroendocrinology · doi:10.1111/jne.12454 · Cited by 12
Kablaoui, N. M., Vanase-Frawley, M. A., & Sciabola, S. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.12.027 · Cited by 12
The effects of oxytocin administration on individuals with ASD: Neuroimaging and behavioral evidence
Baker, E. J., & Stavropoulos, K. K. M. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.04.009 · Cited by 12
Pantouli, F., Pujol, C., Derieux, C., Fonteneau, M., Pellissier, L. P., MARSOL, C., Karpenko, J., Bonnet, D., Hibert, M., Bailey, A., et al. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01915-1 · Cited by 11
Yamasue, H. (2015) · Neuroscience Research · doi:10.1016/j.neures.2015.05.007 · Cited by 11
Current status of biological treatment options in Autism Spectrum Disorder
Eapen, V., Nicholls, L. E., Spagnol, V., & Mathew, N. E. (2017) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2017.07.025 · Cited by 11
-Phasic Model of xytocin (): A systematic conceptual review of oxytocin-related ERP research
Pehlivanoglu, D., Myers, E., & Ebner, N. C. (2020) · Biological Psychology · doi:10.1016/j.biopsycho.2020.107917 · Cited by 11
Oxytocin and object preferences in the male prairie vole
Madularu, D., Athanassiou, M., Yee, J. R., Kenkel, W. M., Carter, C. S., & Mumby, D. G. (2014) · Peptides · doi:10.1016/j.peptides.2014.08.015 · Cited by 11
Dumais, K. M., & Veenema, A. H. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-802114-9.00011-1 · Cited by 11
Grigorenko, E. L. (2011) · Wiley eBooks · doi:10.1002/9781118092699.ch3 · Cited by 11
Marí-Bauset, S., Peraita-Costa, I., Donat-Vargas, C., Llopis-González, A., Marí-Sanchis, A., Llopis-Morales, J., & Morales Suárez-Varela, M. (2022) · Autism · doi:10.1177/13623613211039950 · Cited by 10
Ameringen, M. V., Fineberg, N. A., Ravindran, A. V., Arnold, P. D., Beaulieu, S., Brakoulias, V., Brietzke, E. M., Dowlati, Y., Drummond, L. M., Ferretti, C. J., et al. (2026) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2025.12.039 · Cited by 12
Self-citationMedications in the treatment of borderline personality disorder 2006
Mercer, D. (2007) · Current Psychiatry Reports · doi:10.1007/s11920-007-0010-1 · Cited by 10
Higashida, H., Oshima, Y., & Yamamoto, Y. (2024) · Peptides · doi:10.1016/j.peptides.2024.171230 · Cited by 10
Lee, R., Chong, B., & Coccaro, E. F. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2116-0 · Cited by 10
Neumann, I. D., & van den Burg, E. H. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139017855.004 · Cited by 10
Novotny, S., Hollander, E., Phillips, A., Allen, A., Wasserman, S., & Iyengar, R. L. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570400433x · Cited by 10
Self-citationMedikamentöse Behandlung der Suizidalität
Pfennig, A., Berghöfer, A., & Bauer, M. (2005) · Verhaltenstherapie · doi:10.1159/000083490 · Cited by 10
Kang, H., Glaser, B. D., Sartorius, A. M., Audunsdottir, K., Kildal, E. S.-M., Nærland, T., Andreassen, O. A., Westlye, L. T., & Quintana, D. S. (2025) · Molecular Psychiatry · doi:10.1038/s41380-024-02871-4 · Cited by 10
Meyer, N., Ratinho, L. R., Greive, S. J., Bacri, L., Thiébot, B., della Rocca, B. M., Chinappi, M., Pelta, J., & Cressiot, B. (2025) · ACS Nano · doi:10.1021/acsnano.5c08031 · Cited by 11
Folsom, T. D., & Fatemi, S. H. (2010) · Advances in neurobiology · doi:10.1007/978-1-4419-7104-3_13 · Cited by 9
Worthington, R. (2012) · Journal of Aggression Conflict and Peace Research · doi:10.1108/17596591211208319 · Cited by 9
Co-Occurring Disorders and Treatment Complexity Within Personality Disorders
Fowler, J. C., & Oldham, J. M. (2013) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.11.2.123 · Cited by 9
Real-time human–robot interaction underlying neurorobotic trust and intent recognition
Bray, L. C. J., Anumandla, S. R., Thibeault, C. M., Hoang, R. V., Goodman, P. H., Dascalu, S. M., Bryant, B. D., & Harris, F. C. (2012) · Neural Networks · doi:10.1016/j.neunet.2012.02.029 · Cited by 9
Vers une théorie clinique intégrée des désordres de la constellation autisitique
Gepner, B. (2012) · Développements · doi:10.3917/devel.010.0005 · Cited by 9
Relationship Quality: Implications for Sleep Quality and Sleep Disorders
Holliday, S. B., & Troxel, W. (2017) · National symposium on family issues · doi:10.1007/978-3-319-64780-7_3 · Cited by 9
Neuroendocrinology and Behavior
Sumiyoshi, T. (2012) · InTech eBooks · doi:10.5772/1666 · Cited by 9
Martins, D. A., Mazibuko, N., Zelaya, F. O., Vasilakopoulou, S., Loveridge, J., Oates, A., Maltezos, S., Mehta, M. A., Wastling, S. J., Howard, M. A., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/563056 · Cited by 9
Reframing oxytocin as a behavioral flexibility hormone
Walle, K. M., Sartorius, A. M., Deilhaug, E., Kang, H., Nærland, T., Andreassen, O. A., Westlye, L. T., & Quintana, D. S. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106628 · Cited by 10
Oxytocin for the treatment of autism spectrum disorder in children
Griffiths, J. L., Mishaal, R. A., Nabetani, M., & Goldman, R. D. (2022) · Canadian Family Physician · doi:10.46747/cfp.6802103 · Cited by 8
Mulryan, C. (2012) · Independent Nurse · doi:10.12968/indn.2012.16.4.91038 · Cited by 8
Mahmuda, N. A., Yokoyama, S., Munesue, T., Hayashi, K., Yagi, K., Tsuji, C., & Higashida, H. (2020) · Diseases · doi:10.3390/diseases8010004 · Cited by 8
Gauthier, C., Doyen, C., Amado, I., Lôo, H., & Gaillard, R. (2016) · L Encéphale · doi:10.1016/j.encep.2015.07.006 · Cited by 8
Psychopharmacology of Neurodevelopmental Disorders in Children
Singh, J., & Santosh, P. (2016) · Springer eBooks · doi:10.1007/978-81-322-3619-1_18 · Cited by 8
Friedlander, E., Yirmiya, N., Laiba, E., Harel‐Gadassi, A., Yaari, M., Feldstein, O., Mankuta, D., & Israel, S. (2019) · Autism Research · doi:10.1002/aur.2111 · Cited by 8
Empathy as a Concept from Bench to Bedside: A Translational Challenge
Uysal, N., Çamsarı, U. M., Ateş, M., Kandiş, S., Karakılıç, A., & Camsari, G. B. (2019) · Nöro Psikiyatri Arşivi · doi:10.29399/npa.23457 · Cited by 8
Rahaman, M. A., Lopa, M., Uddin, K. M. F., Baqui, M. A., Keya, S. P., Faruk, M. O., Sarker, S., Basiruzzaman, M., Islam, M., Albanna, A., et al. (2020) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-020-04703-0 · Cited by 8
Kawamura, Y., Liu, X., Shimada, T., Otowa, T., Kakiuchi, C., Akiyama, T., Umekage, T., & Sasaki, T. (2011) · Asia-Pacific Psychiatry · doi:10.1111/j.1758-5872.2011.00132.x · Cited by 7
From Parental Behavior to Sexual Function: Recent Advances in Oxytocin Research
Dale, J. K., Harberson, M. T., & Hill, J. W. (2024) · Current Sexual Health Reports · doi:10.1007/s11930-024-00386-1 · Cited by 7
Wu, G., Ou, Y., Feng, Z., Xiong, Z., Li, K., Che, M., Qi, S., & Zhou, M. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02930-y · Cited by 7
Personality Disorders, Attachment and Psychodynamic Psychotherapy
Weinstein, L., Pérez-Rodríguez, M. M., & Siever, L. J. (2014) · Psychopathology · doi:10.1159/000366135 · Cited by 7
Neurotoxic Brainstem Impairment as Proposed Threshold Event in Autistic Regression
McGinnis, W. R., Miller, V. M., AUDHYA, T. K., & Edelson, S. B. (2009) · CRC Press eBooks · doi:10.1201/9781420068870-c9 · Cited by 7
Brain Oxytocin is a Main Regulator of Prosocial Behaviour - Link to Psychopathology
Lukas, M., & Inga, N. (2011) · InTech eBooks · doi:10.5772/18841 · Cited by 7
Tom, N., & Assinder, S. J. (2010) · BioMolecular Concepts · doi:10.1515/bmc.2010.036 · Cited by 7
Comparative Cognition and Neuroscience
Snowdon, C. T., & Cronin, K. A. (2009) · Wiley eBooks · doi:10.1002/9780470478509.neubb001004 · Cited by 7
Kirsch, P., & Meyer-Lindenberg, A. (2010) · The Neurochemical Basis of Autism · doi:10.1007/978-1-4419-1272-5_10 · Cited by 6
Metadata
- Authors
- Hollander, E., Novotny, S., Hanratty, M., Yaffe, R., DeCaria, C. M., Aronowitz, B. R., & Mosovich, S.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- Corresponding author
- Hollander, Eric
- ORCID
- Hollander, Eric
- Venue
- Neuropsychopharmacology
- Published
- 2003-01
- Volume
- 28
- Issue
- 1
- Pages
- 193-198
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2036441276
- Cited by
- 689
- References
- 60
- Citations by year
- 2026: 7 · 2025: 14 · 2024: 15 · 2023: 15 · 2022: 23 · 2021: 22 · 2020: 27 · 2019: 15 · 2018: 29 · 2017: 33 · 2016: 47 · 2015: 49 · 2014: 49 · 2013: 51 · 2012: 44
- FWCI
- 29.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Alliance for Research on Schizophrenia and Depression
- National Institutes of Health
- National Center for Research Resources (5 M01RR00071, M01RR000071)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Keywords
- oxytocin, repetitive behavior, autism spectrum disorder, Asperger syndrome, autistic adults, oxytocin infusion, vasopressin, social behavior, self-harm, need to know, ordering behavior
- MeSH terms
- Adult, Autistic Disorder, Blood Pressure, Body Temperature, Double-Blind Method, Female, Humans, Infusions, Intravenous, Male, Oxytocin, Psychiatric Status Rating Scales, Pulse, Treatment Outcome, Asperger Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
